Dr. William Ho has contributed to 4 publications.
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma.
Li, D.,Poon, K. A.,Yu, S. F.,Dere, R.,Go, M.,Lau, J.,Zheng, B.,Elkins, K.,Danilenko, D.,Kozak, K. R.,Chan, P.,Chuh, J.,Shi, X.,Nazzal, D.,Fuh, F.,McBride, J.,Ramakrish...; Mol. Cancer Ther.. 2013 Jul.
See more >>
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients.
Chapuis, A. G.,Ragnarsson, G. B.,Nguyen, H. N.,Chaney, C. N.,Pufnock, J. S.,Schmitt, T. M.,Duerkopp, N.,Roberts, I. M.,Pogosov, G. L.,Ho, W. Y.,Ochsenreither, S.,Wölfl...; Sci Transl Med. 2013 Feb 27.
See more >>
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowl...
Wolfl, M., Kuball, J., Ho, W.Y., Nguyen, H., Manley, T.J., Bleakley, M., Greenberg, P.D.; Blood. 2007 Jul 1.
See more >>
Facilitating matched pairing and expression of TCR chains introduced into human T cells.
Kuball, J., Dossett, M.L., Wolfl, M., Ho, W.Y., Voss, R., Fowler, C., Greenberg, P.D.; Blood. 2007 Mar 15.
See more >>